Skip to Main Content

Paper Details

Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner.
Sci Rep
5
2022
AKT, AKTi, BMS-754807, Capivasertib, Foretinib, HDAC, HDACi, IGF-1R, IGF-1Ri, Ipatasertib, MET, METi, Panobinostat, SD, SD cells, VEGFR2, Vorinostat, Whole genome arrays, patients, prostate cancer, prostate cancer cells
Author NameAffiliation
Lance A LiottaCenter for Applied Proteomics and Molecular Medicine, George Mason University
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University
  • 1 - 3

Datasets

Release 1.2